20255-94-1

Basic information

• Product Name: 1 2-DIMYRISTOYL-RAC-GLYCEROL (C14:0)
• Synonyms: 1 2-DIMYRISTOYL-RAC-GLYCEROL (C14:0);1-(hydroxymethyl)ethylene dimyristate;1-(Hydroxymethyl)ethylendimyristat;Glyceryl 1,2-dimyristate;1,2-Dimyristin, 1,2-Ditetradecanoyl-rac-glycerol;(1-hydroxy-3-tetradecanoyloxy-propan-2-yl) tetradecanoate;(1-hydroxy-3-tetradecanoyloxypropan-2-yl) tetradecanoate;myristic acid (1-methylol-2-tetradecanoyloxy-ethyl) ester
• CAS NO: 20255-94-1
• Molecular Formula: C₃₁H₆₀O₅
• Molecular Weight: 512.8051
• EINECS: 243-643-4
• Mol File: 20255-94-1.mol
• Article Data: 8

Chemical Properties

• Melting Point: 59℃
• Boiling Point: 577.2°Cat760mmHg
• Flash Point: 166.8°C
• Appearance: /
• Density: 0.940
• Vapor Pressure: 1E-15mmHg at 25°C
• Refractive Index: 1.465
• Storage Temp.: −20°C
• CAS DataBase Reference: 1 2-DIMYRISTOYL-RAC-GLYCEROL (C14:0)(CAS DataBase Reference)
• NIST Chemistry Reference: 1 2-DIMYRISTOYL-RAC-GLYCEROL (C14:0)(20255-94-1)
• EPA Substance Registry System: 1 2-DIMYRISTOYL-RAC-GLYCEROL (C14:0)(20255-94-1)

Safety Data

• WGK Germany: 1
• Hazardous Substances Data: 20255-94-1(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 20255-94-1 differently. You can refer to the following data:
1. 1,2-Dimyristoyl-rac-glycerol is used to synthesize lipophilic peptides for gene delivery.
2. 1,2-Dimyristoyl-rac-glycerol is used to synthesize?lipophilic peptides for gene delivery.

Description

DMG (1,2-Dimyristoyl-rac-glycerol) is a carboxylic ester, glycerolipid and diglyceride with an attached myristoyl group, promoting interactions between proteins and lipids. It can be employed as a detergent or reagent. It's functional in cell biology experimentation concerning metabolism and metabolic pathways involving glycerolipids. As a diglyceride, the substance consists of two fatty acid chains covalently bonded to the glycerol molecule in the 1,2- formation. Diglyceride (DAG) research investigates the process of suppressing fat accumulation through DAG consumption.

Definition

ChEBI: A 1,2-diglyceride in which the acyl groups at positions 1 and 2 are specifed as tetradecanoyl.

InChI:InChI=1/C31H60O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-30(33)35-28-29(27-32)36-31(34)26-24-22-20-18-16-14-12-10-8-6-4-2/h29,32H,3-28H2,1-2H3

Upstream product

• 96-13-9 2,3-Dibromopropan-1-ol 
• 13429-27-1 potassium myristate 
• 7770-09-4 glycerol 1,3-dimyristate 
• 56176-80-8 1-(tert-butyl)dimethylsilyl-2,3-dimyristoyl glycerol 
• 73083-33-7 3-(benzyloxy)propane-1,2-diyl ditetradecanoate 
• 18194-24-6 dimyristoylphosphatidylcholine 
• 544-63-8 n-tetradecanoic acid 
• 124-10-7 methyl myristoate 
• 56-81-5 glycerol 
• 132333-70-1 tetradecanoic acid 2-oxopropane-1,3-diyl ester 
• 22128-29-6 3-(1-ethoxy-ethoxy)-propane-1,2-diol 
• 112-64-1 tetradecanoyl chloride 

Downstream Products

• 76163-46-7 diphenyl 1,2-di-O-tetradecanoyl-rac-3-glycerophosphate 
• 177084-32-1 Tetradecanoic acid 2-{diisopropylamino-[2-(4-nitro-phenyl)-ethoxy]-phosphanyloxy}-1-tetradecanoyloxymethyl-ethyl ester 
• 163333-49-1 Tetradecanoic acid 2-((S)-3-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-2-tert-butoxycarbonylamino-propionyloxy)-1-tetradecanoyloxymethyl-ethyl ester 
• 149204-03-5 2,3-dimyristoylglycerol-tosylate 
• 30170-00-4 Dimyristoylphosphatidic acid 
• 177084-37-6 Tetradecanoic acid 2-{[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethoxy]-[2-(4-nitro-phenyl)-ethoxy]-phosphoryloxy}-1-tetradecanoyloxymethyl-ethyl ester 
• 177084-41-2 3'-deoxy-N⁶,2'-O-bis<2-(4-nitrophenyl)ethoxycarbonyl>adenosine 5'-<(2RS)-2,3-bis(tetradecanoyloxy)-propyl 2-(4-nitrophenyl)ethyl phosphate> 
• 177084-45-6 3'-deoxy-N⁶,5'-O-bis<2-(4-nitrophenyl)ethoxycarbonyl>adenosine 2'-<(2RS)-2,3-bis(tetradecanoyloxy)-propyl 2-(4-nitrophenyl)ethyl phosphate> 
• 7770-09-4 glycerol 1,3-dimyristate 
• 18194-24-6 dimyristoylphosphatidylcholine 
• 20255-95-2 dimyristoylphosphatidylethanolamine 

Relevant articles and documents

Temperature dependence of production of structured triacylglycerols in the alga Trachydiscus minutus

This study describes the identification of regioisomers and enantiomers of triacylglycerols of C20 polyunsaturated fatty acids (PUFAs) in the alga Trachydiscus minutus cultivated at different temperatures using reversed- and chiral-phase liquid chromatogr

HYDROPHOBIC ACID ADDITION SALTS AND PHARMACEUTICAL FORMULATIONS THEREOF

The invention provides hydrohphobic drug salts and pharmaceutical compositions comprising such salts. The invention fourther provides compositions for delivering poorly soluble drugs, including hydrophobic drug salts.

COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS

This disclosure provides improved lipid-based compositions, including lipid nanoparticle compositions, and methods of use thereof for delivering agents in vivo including nucleic acids and proteins. These compositions are not subject to accelerated blood clearance and they have an improved toxicity profile in vivo.